Infinity Pharmaceuticals | INFI - DEBITO





DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Grifols EUR 9.23B 626.05M 2024-12
Incyte USD 40.41M 855K 2025-12
Infinity Pharmaceuticals USD 0 0 2022-06
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
J&J USD 45.8B 4.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 245.34M 8.38M 2025-09